Incidence and Associated Risk Factors of Venous Thromboembolism After Open and Laparoscopic Nephrectomy in Patients Administered Short-period Thromboprophylaxis: A Danish Nationwide Population-based Cohort Study.
Aged
Anticoagulants
/ administration & dosage
Denmark
/ epidemiology
Female
Humans
Incidence
Laparoscopy
/ adverse effects
Length of Stay
/ statistics & numerical data
Male
Middle Aged
Nephrectomy
/ adverse effects
Postoperative Complications
/ epidemiology
Registries
/ statistics & numerical data
Retrospective Studies
Risk Factors
Venous Thromboembolism
/ epidemiology
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
11
03
2020
revised:
03
06
2020
accepted:
09
06
2020
pubmed:
23
6
2020
medline:
4
2
2022
entrez:
23
6
2020
Statut:
ppublish
Résumé
To report the incidence of venous thromboembolism (VTE) after nephrectomy in Denmark and explore associated risk factors. A nationwide population-based retrospective cohort study was performed. All nephrectomies from January 2010 to August 2018 were assessed for postoperative VTE events. Univariable and multivariable analyses were used to evaluate the odds ratio (OR) of clinical variables' effect on postoperative VTEs, within 4 weeks and 4 months after nephrectomy. In 5213 nephrectomized patients, postoperative VTE incidence was 1% and 2% within 4 weeks and 4 months, respectively. Multivariable analyses revealed that predictors of postoperative VTE within 4 months were: open nephrectomy (OR 2.5, P = .001), history of VTE (OR 13.3, P <.001), length of hospital stay (OR 0.98, P = .02), and lymph node dissection (OR 2.0, P = .04). Limitations included the retrospective and registry-based study design and absence of individual patient data on patient body mass index and length of surgery. For nephrectomy, postoperative VTE is rare. Open nephrectomy, history of VTE, length of hospital stay, and lymph node dissection are important risk factors which should be evaluated when tailoring VTE prophylaxis regimens.
Identifiants
pubmed: 32569656
pii: S0090-4295(20)30705-6
doi: 10.1016/j.urology.2020.06.007
pii:
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112-116Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.